Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstacles and their efficacy on blood pressure (BP) control. Methods: Sixty-three intervention and 61 control centers with 2483 (mean age: 58.0 years, 56.0% male) drug-naïve stage 2 hypertensive patients or patients requiring second anti-hypertensive medications were included. The intervention group was instructed to measure HBP twice a day for 7 days from the scheduled visit at 4, 8, and 12 weeks. Results: At the end of 12 weeks, 842 (68.7%) and 807 (64.15%) patients of the control and intervention groups, respectively, achieved a target BP. The odds ratio (OR) for improving BP control of HBP was 0.836 (95% confidence interval [CI]: 0.694–1.007). Among intervention group, clinic BP of the subgroup those measured their HBP at least once well controlled compared to subgroup those not measured their HBP at all (OR 1.602, 95% CI: 1.182–2.172). Only 19.17% (n = 476) had a home sphygmomanometer, and among those, 26.89% measured their BP at least once a week and 34.87% did not measure the BP at all. The obstacles of HBP measurement were lack of awareness of its importance (40.83%), lack of confidence on how to measure BP and maintain the measurement (37.04%), and difficulty in selecting an appropriate device (14.41%). Conclusions: HBP measurement alone did not improve BP control, but better compliance with the HBP measurement resulted in improved BP control. Trial registration: ClinicalTrials, NCT03254914, Registered 21 August 2017
Abstract
Background: Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstacles and their efficacy on blood pressure (BP) control. Methods: Sixty-three intervention and 61 control centers with 2483 (mean age: 58.0 years, 56.0% male) drug-naïve stage 2 hypertensive patients or patients requiring second anti-hypertensive medications were included. The intervention group was instructed to measure HBP twice a day for 7 days from the scheduled visit at 4, 8, and 12 weeks. Results: At the end of 12 weeks, 842 (68.7%) and 807 (64.15%) patients of the control and intervention groups, respectively, achieved a target BP. The odds ratio (OR) for improving BP control of HBP was 0.836 (95% confidence interval [CI]: 0.694–1.007). Among intervention group, clinic BP of the subgroup those measured their HBP at least once well controlled compared to subgroup those not measured their HBP at all (OR 1.602, 95% CI: 1.182–2.172). Only 19.17% (n = 476) had a home sphygmomanometer, and among those, 26.89% measured their BP at least once a week and 34.87% did not measure the BP at all. The obstacles of HBP measurement were lack of awareness of its importance (40.83%), lack of confidence on how to measure BP and maintain the measurement (37.04%), and difficulty in selecting an appropriate device (14.41%). Conclusions: HBP measurement alone did not improve BP control, but better compliance with the HBP measurement resulted in improved BP control. Trial registration: ClinicalTrials, NCT03254914, Registered 21 August 2017
참고문헌 (33)
- GBD 2017 Risk Factor Collaborators, "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.e44~ (2019)
- Fagard RH, "Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice", J Hum Hypertens, 19, pp.801~807 (2005)
- Niiranen TJ, "Homemeasured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure : the Finn-home study", Hypertension, 55, pp.1346~1351 (2010)
- Asayama K, "Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis", PLoS Med, 11, pp.e1001591~ (2014)
- Agarwal R, "Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control : a systematic review and meta-analysis", Hypertension, 57, pp.29~38 (2011)
- Pickering TG, "Call to action on use and reimbursement for home blood pressure monitoring : a joint scientific statement from the American Heart Association, American Society of Hypertension, and preventive cardiovascular nurses association", J Cardiovasc Nurs, 23, pp.299~323 (2008)
- 신진호, "2013 Korean Society of Hypertension guidelines for the management of hypertension. Part I—epidemiology and diagnosis of hypertension", Clinical Hypertension, 21(1), pp.1~11 (2015), 대한고혈압학회[DOI]
- Park S, "Korean physician perceptions of home blood pressure monitoring(HBPM)for hypertension patients", J Hypertens, 34, pp.e530~e531 (2016)
- Rahman ARA, "all members of the Asian cardiovascular expert forum committee. Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control", Asia Pac Fam Med, 14, pp.2~ (2015)
- "Hypertension in adults:diagnosis and management" (2019)[URL]
- ESC practice guidelines for the management of arterial hypertension, 23, "2013ESH", pp.2014, Mancia G
- Weber MA, "Clinical practice guidelines for the management of hypertension in the community : a statement by the American Society of Hypertension and the International Society of Hypertension", J Clin Hypertens, 16, pp.14~24 (2014)
- Gabb GM, "Guideline for the diagnosis and management of hypertension in adults – 2016", Med J Aust, 205, pp.85~89 (2016)
- Leung AA, "Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension", Can J Cardiol, 32, pp.569~588 (2016)
- Kario K, "Key points of the Japanese Society of Hypertension guidelines for the management of hypertension in 2014", Pulse, 3, pp.35~47 (2015)
- Kario K, "Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy : primary results of HONEST, a large-scale prospective, real-world observational study", Hypertension, 64, pp.989~996 (2014)
- Yutaka I, "Remote blood pressure monitoring in hypertension care practice of hypertension by teletransmission of home blood pressure", J. Hypertens, 34, pp.e364~e365 (2016)
- Lim SS, "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010 : a systematic analysis for the global burden of disease study 2010", Lancet, 380, pp.2224~2260 (2012)
- Mills KT, "The global epidemiology of hypertension", Nat Rev Nephrol, 16, pp.223~237 (2020)
- "Statistics for older adults 2019" (2019)[URL]
- Kwang-Il Kim, "Optimal Management of Chronic Medical Conditions Through Digital Medicine", Annals of geriatric medicine and research, 22(3), pp.117~120 (2018), 대한노인병학회[DOI]
- "Clinical trial guidelines for antihypertensive drugs" (2015)[URL]
- 신진호, "2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension", Clinical Hypertension, 21(2), pp.1~13 (2015), 대한고혈압학회[DOI]
- Cho EJ, "Fimasartan reduces clinic and home pulse pressure in elderly hypertensive patients : a K-MetS study", PLoS One, 14, pp.e0214293~ (2019)
- Kim SY, "Clinic and home blood pressure lowering effect of an angiotensin receptor blocker, fimasartan, in postmenopausal women with hypertension", Medicine, 95, pp.e3764~ (2016)
- George J, "Home blood pressure monitoring", Eur Cardiol, 10, pp.95~101 (2015)
- Cappuccio FP, "Blood pressure control by home monitoring : meta-analysis of randomised trials", BMJ, 329, pp.145~ (2014)
- Bray EP, "Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials", Ann Med, 42, pp.371~386 (2010)
- Glynn LG, "Interventions used to improve control of blood pressure in patients with hypertension", Cochrane Database Syst Rev, 3, pp.CD005182~ (2010)
- Angell S, "Integrating self blood pressure monitoring into the routine management of uncontrolled hypertension : translating evidence to practice", J Clin Hypertens, 15, pp.180~185 (2013)
- Duan Y, "Effectiveness of home blood pressure telemonitoring : a systematic review and meta-analysis of randomized controlled studies", J Clin Hypertens, 31, pp.427~437 (2017)
- Spirk D, "Effect of home blood pressure monitoring on patient's awareness and goal attainment under antihypertensive therapy : the Factors Influencing Results in anti-HypertenSive Treatment(FIRST)Study", Kidney Blood Press Res, 43, pp.979~986 (2018)
- Kim J, "Compliance with home blood pressure monitoring among middle-aged Korean Americans with hypertension", J Clin Hypertens, 12, pp.253~260 (2010)